LSERS
NBIX icon

Louisiana State Employees Retirement System’s Neurocrine Biosciences NBIX Stock Holding History

Louisiana State Employees Retirement System’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.95M Buy
29,400
+300
+1% +$44.5K 0.07% 198
2026
Q1 		$3.83M Buy
29,100
+1,500
+5% +$199K 0.07% 231
2025
Q4 		$3.91M Hold
27,600
– – 0.07% 219
2025
Q3 		$3.87M Sell
27,600
-200
-0.7% -$27.1K 0.07% 240
2025
Q2 		$3.49M Sell
27,800
-100
-0.4% -$11.5K 0.06% 243
2025
Q1 		$3.09M Sell
27,900
-200
-0.7% -$25.3K 0.06% 258
2024
Q4 		$3.84M Buy
28,100
+100
+0.4% +$12.4K 0.07% 212
2024
Q3 		$3.23M Sell
28,000
-500
-2% -$68.5K 0.06% 269
2024
Q2 		$3.92M Sell
28,500
-100
-0.3% -$13.7K 0.08% 193
2024
Q1 		$3.94M Buy
28,600
+1,000
+4% +$137K 0.08% 202
2023
Q4 		$3.64M Sell
27,600
-100
-0.4% -$11.5K 0.08% 203
2023
Q3 		$3.12M Sell
27,700
-800
-3% -$84.2K 0.07% 212
2023
Q2 		$2.69M Buy
28,500
+2,900
+11% +$283K 0.06% 263
2023
Q1 		$2.59M Sell
25,600
-100
-0.4% -$10.4K 0.07% 239
2022
Q4 		$3.07M Buy
25,700
+300
+1% +$35.1K 0.08% 197
2022
Q3 		$2.7M Buy
25,400
+300
+1% +$30.4K 0.08% 200
2022
Q2 		$2.42M Buy
25,100
+300
+1% +$27.7K 0.06% 241
2022
Q1 		$2.43M Buy
24,800
+400
+2% +$33.9K 0.06% 293
2021
Q4 		$2.08M Buy
24,400
+300
+1% +$27.6K 0.05% 394
2021
Q3 		$2.31M Sell
24,100
-400
-2% -$37.8K 0.06% 293
2021
Q2 		$2.38M Buy
24,500
+200
+0.8% +$19.2K 0.06% 294
2021
Q1 		$2.36M Buy
+24,300
New +$2.55M 0.06% 282

Other funds holding NBIX

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PBBUPS
PKO BP Bankowy Universal Pension Society Warsaw, Poland $350M AUM 272.18% 1-Year Est. Return
AS
Aware Super Sydney, Australia $7.06B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Louisiana State Employees Retirement System's NBIX Position: Q2 2026 in Review

Louisiana State Employees Retirement System increased its Neurocrine Biosciences (NBIX) stake by 1% in Q2 2026, buying an estimated $44.5K and bringing the position to 29,400 shares worth $4.95M. The position accounts for 0.07% of the portfolio, ranked #198.

Louisiana State Employees Retirement System first reported a position in NBIX in Q1 2021 and has held it in 22 quarters since. 260 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • Louisiana State Employees Retirement System held 29,400 shares of Neurocrine Biosciences worth $4.95M as of Q2 2026.
  • Louisiana State Employees Retirement System bought 300 Neurocrine Biosciences shares in Q2 2026, an estimated $44.5K.
  • Neurocrine Biosciences made up 0.07% of Louisiana State Employees Retirement System's portfolio in Q2 2026, its #198 holding.
  • Louisiana State Employees Retirement System first reported a position in Neurocrine Biosciences in Q1 2021 and has held it in 22 quarters since.
  • 260 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on Louisiana State Employees Retirement System's 13F filing for Q2 2026, filed 20 Jul 2026.